Skip to content
Duke University Office for Translation & Commercialization
  • By the Numbers
  • Start-Ups
  • Stories
  • Previous Reports
    • 2021
    • 2020
    • 2019
    • 2018

Category: Start-ups

XPara Mutualistic Helminths

Posted on October 21, 2022 | by Fedor Kossakovski | Leave a Comment on XPara Mutualistic Helminths

XPara Mutualistic Helminths is developing therapeutics for chronic diseases based on helminth parasites.

Posted in Start-ups

Warden Bio

Posted on October 21, 2022 | by Fedor Kossakovski | Leave a Comment on Warden Bio

Warden Bio, now a part of Kriya Therapeutics, is developing novel AAV-mediated gene therapies for glycogen storage disorders.

Posted in Start-ups

Versametrics

Posted on October 21, 2022 | by Fedor Kossakovski | Leave a Comment on Versametrics

Versametrics is developing automated, longer-term approaches to testing electronic devices for research and industrial use.

Posted in Start-ups

Tune Therapeutics

Posted on October 21, 2022 | by Fedor Kossakovski | Leave a Comment on Tune Therapeutics

Tune Therapeutics is pioneering the creation of new medicines using an epigenomic control platform.

Posted in Start-ups

Sonokine Biosciences

Posted on October 21, 2022 | by Fedor Kossakovski | Leave a Comment on Sonokine Biosciences

Sonokine Biosciences is developing cancer treatments that use high intensity focused ultrasound in combination with targeted delivery of immune therapies.

Posted in Start-ups

Solar Unsoiled

Posted on October 21, 2022 | by Fedor Kossakovski | Leave a Comment on Solar Unsoiled

Solar Unsoiled is an interactive, data-driven platform to optimize global solar energy production by targeting optimization surrounding soiling losses.

Posted in Start-ups

Sentinel Medical Innovations

Posted on October 21, 2022 | by Fedor Kossakovski | Leave a Comment on Sentinel Medical Innovations

Sentinel Medical Innovations is developing medical devices to protect from oral trauma during surgical procedures.

Posted in Start-ups

Minutia

Posted on October 21, 2022 | by Fedor Kossakovski | Leave a Comment on Minutia

Minutia aims to develop stem cell-derived transplants that can communicate transplant status in vivo and that are resistant to common transplant challenges.

Posted in Start-ups

Forewarned

Posted on October 21, 2022 | by Fedor Kossakovski | Leave a Comment on Forewarned

Forewarned is establishing network and enterprise security for safer online environment using STINGAR to improve the safety of all users.

Posted in Start-ups
Black lab with faunalabs collar, out in nature

FaunaLabs

Posted on October 21, 2022 | by Fedor Kossakovski | Leave a Comment on FaunaLabs

FaunaLabs is developing the next generation of animal collars to measure cardiovascular health through the fur of dogs, cats, horses, and cattle.

Posted in Start-ups

Posts navigation

Older posts

Recent Posts

  • Student engagement along the innovation and entrepreneurship process: how Duke student fellows assist OTC in tech assessment, marketing, and investment
  • Duke Capital Partners joins the Office for Translation & Commercialization
  • Tune Therapeutics Launches with Pioneering Epigenomic Control Platform to Master Gene Networks, Treat Broad Range of Diseases
  • Venture Day 2022 Highlights Early-stage Life-science Companies in the Triangle
  • Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant

Recent Comments

    Archives

    • October 2022

    Categories

    • Start-ups
    • Stories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
      Click here for enhanced color contrast.
    • VISIT OTC.DUKE.EDU
    • © 2021 Duke Office for Translation & Commercialization